Table 4:
Specifics of the personalised screening scenarios, when costs and QALYs are discounted at 5%a
| Screening Strategy | Risk Groups |
||||
|---|---|---|---|---|---|
| Very Low | Low | Average | High | Very High | |
| PS1 | NoScr | NoScr | NoScr | NoScr | FIT_60_1 |
| PS2 | NoScr | NoScr | NoScr | NoScr | FIT_54_1 |
| PS3 | NoScr | NoScr | NoScr | FIT_60_2 | FIT_54_1 |
| PS4 | NoScr | NoScr | NoScr | FIT_60_1 | FIT_54_1 |
| PS5 | NoScr | NoScr | NoScr | FIT_54_2 | FIT_54_1 |
| PS6 | NoScr | NoScr | NoScr | FIT_54_1 | FIT_54_1 |
| PS7 | NoScr | NoScr | FIT_60_2 | FIT_54_1 | FIT_54_1 |
| PS8 | NoScr | NoScr | FIT_54_2 | FIT_54_1 | FIT_54_1 |
| PS9 | NoScr | NoScr | FIT_54_2 | FIT_54_1 | FIT_50_1 |
| PS10 | NoScr | FIT_60_2 | FIT_54_2 | FIT_54_1 | FIT_50_1 |
| PS11 | NoScr | FIT_54_2 | FIT_54_2 | FIT_54_1 | FIT_50_1 |
| PS12 | NoScr | FIT_54_2 | FIT_54_1 | FIT_54_1 | FIT_50_1 |
| PS13 | NoScr | FIT_54_2 | FIT_54_1 | FIT_50_1 | FIT_50_1 |
| PS14 | FIT_54_3 | FIT_54_2 | FIT_54_1 | FIT_50_1 | FIT_50_1 |
| PS15 | FIT_54_2 | FIT_54_2 | FIT_54_1 | FIT_50_1 | FIT_50_1 |
| PS16 | FIT_54_2 | FIT_54_2 | FIT_54_1 | FIT_50_1 | COL_54_5 |
| PS17 | FIT_54_2 | FIT_54_2 | FIT_54_1 | FIT_50_1 | COL_50_5 |
| PS18 | FIT_54_2 | FIT_54_1 | FIT_54_1 | FIT_50_1 | COL_50_5 |
| PS19 | FIT_54_2 | FIT_54_1 | FIT_50_1 | FIT_50_1 | COL_50_5 |
| PS20 | FIT_54_2 | FIT_50_1 | FIT_50_1 | FIT_50_1 | COL_50_5 |
| PS21 | FIT_50_2 | FIT_50_1 | FIT_50_1 | FIT_50_1 | COL_50_5 |
| PS22 | FIT_50_2 | FIT_50_1 | FIT_50_1 | COL_50_5 | COL_50_5 |
| PS23 | FIT_50_2 | FIT_50_1 | FIT_50_1 | COL_50_5 | COL_46_5 |
| PS24 | FIT_54_1 | FIT_50_1 | FIT_50_1 | COL_50_5 | COL_46_5 |
| PS25 | FIT_50_1 | FIT_50_1 | FIT_50_1 | COL_50_5 | COL_46_5 |
| PS26 | FIT_50_1 | FIT_50_1 | FIT_46_1 | COL_50_5 | COL_46_5 |
| PS27 | FIT_50_1 | FIT_50_1 | FIT_46_1 | COL_50_5 | COL_40_5 |
| PS28 | FIT_50_1 | FIT_50_1 | FIT_46_1 | COL_46_5 | COL_40_5 |
| PS29 | FIT_50_1 | FIT_50_1 | COL_50_5 | COL_46_5 | COL_40_5 |
| PS30 | FIT_50_1 | FIT_46_1 | COL_50_5 | COL_46_5 | COL_40_5 |
| PS31 | FIT_46_1 | FIT_46_1 | COL_50_5 | COL_46_5 | COL_40_5 |
| PS32 | FIT_46_1 | FIT_46_1 | COL_50_5 | COL_40_5 | COL_40_5 |
| PS33 | FIT_46_1 | FIT_46_1 | COL_46_5 | COL_40_5 | COL_40_5 |
| PS34 | FIT_46_1 | COL_50_5 | COL_46_5 | COL_40_5 | COL_40_5 |
| PS35 | FIT_46_1 | COL_46_5 | COL_46_5 | COL_40_5 | COL_40_5 |
| PS36 | FIT_46_1 | COL_46_5 | COL_40_5 | COL_40_5 | COL_40_5 |
| PS37 | COL_50_5 | COL_46_5 | COL_40_5 | COL_40_5 | COL_40_5 |
| PS38 | COL_50_5 | COL_40_5 | COL_40_5 | COL_40_5 | COL_40_5 |
| PS39 | COL_46_5 | COL_40_5 | COL_40_5 | COL_40_5 | COL_40_5 |
Abbreviations: COL = colonoscopy; FIT = faecal immunochemical test, NoScr = no screening
Screening strategies: Screening test, screening start age, screening interval
a.
All screening ends at or before the age of 74 years